Suchergebnisse - "Shafat, Tali"

PubPharm (2)

1

An international multicenter study comparing COVID-19 omicron outcomes in patients with hematological malignancies treated with obinutuzumab versus rituximab

enthalten in: Cancer medicine | 2024

von Shafat, T. | Grupel, D. | Porges, T. | +25

2

Treatment with obinutuzumab leads to worse outcomes in haematological patients diagnosed with Omicron variant COVID-19

enthalten in: British journal of haematology | 2022

von Shafat, T. | Grupel, D. | Porges, T. | +3

1
[1]